secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001437749-25-031054
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health enters new CEO employment agreement with Jennifer Ernst; base salary $325K
--------------------------------------------------------------------------------

- Jennifer Ernst, CEO, enters new employment agreement effective Oct 8, 2025, replacing prior offer letter.
- Base salary of $325,000 per annum; eligible for annual bonus up to 50% of base salary at Board discretion.
- Severance: 12 months of base salary continuation, COBRA coverage, and continued equity vesting if terminated without cause or for good reason.
- Severance conditioned on signing a release; no severance for voluntary quit (except good reason), cause, death, or disability.
- Employment remains 'at will'; prior confidentiality and arbitration agreements remain in force.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000143774925031054/0001437749-25-031054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000143774925031054/tivc20251010_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-031054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer